CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,027 | $578.05 | $1.2M | 42,808 |
| 2026-04-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,750 | $579.36 | $1.0M | 41,058 |
| 2026-04-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −385 | $579.84 | $223K | 40,673 |
| 2026-04-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $581.33 | $93K | 40,513 |
| 2026-04-16 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 26,500 | ||
| 2026-04-16 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise 10b5-1 | +8,300 | $146.03 | $1.2M | 53,472 |
| 2026-04-16 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −200 | $574.03 | $115K | 53,272 |
| 2026-04-16 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,640 | $575.37 | $944K | 51,632 |
| 2026-04-16 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,800 | $576.38 | $1.0M | 49,832 |
| 2026-04-16 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −3,366 | $577.39 | $1.9M | 46,466 |
| 2026-04-16 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,294 | $578.21 | $748K | 45,172 |
| 2026-04-16 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise · Stock Option 10b5-1 | −8,300 | 8,600 | ||
| 2026-04-15 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-04-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $575.29 | $46K | 49,933 |
| 2026-04-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −880 | $576.98 | $508K | 49,053 |
| 2026-04-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −629 | $577.81 | $363K | 48,424 |
| 2026-04-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −684 | $579.14 | $396K | 47,740 |
| 2026-04-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,255 | $580.02 | $1.3M | 45,485 |
| 2026-04-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,819 | $581.05 | $1.6M | 42,666 |
| 2026-04-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,624 | $582.05 | $945K | 41,042 |
Page 123 of 171 · 3,408 trades